Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-09-10

AUTHORS

Aayush Khanal, Arun Sharma, Srijana Basnet, Pushpa Raj Sharma, Fakir Chandra Gami

ABSTRACT

BACKGROUND: To Assess the efficacy of nebulised hypertonic saline (HS) (3%) among children with mild to moderately severe bronchiolitis. METHODS: Infants aged 6 weeks to 24 months, with a first episode of wheezing and Clinical Severity scores (Arch Dis Child 67:289-93, 1992) between 1 and 8, were enrolled over 4 months duration. Those with severe disease, co-morbidities, prior wheezing, recent bronchodilator and steroid use were excluded. Patients were randomized in a double-blind fashion, to receive two doses of nebulized 3% HS (Group 1) or 0.9% normal saline (Group 2) with 1.5 mg of L-Epineprine, delivered 30 min apart. Parents were contacted at 24 h and 7 days. The principal outcome measure was the mean change in clinical severity score at the end of 2 h of observation. RESULTS: A total of 100 infants (mean age 9.6 months, range 2-23 months; 61 % males) were enrolled. Patients in both groups had mild to moderately severe disease at presentation. On an intention-to-treat basis, the infants in the HS group had a significant reduction (3.57 ± 1.41) in the mean clinical severity score compared to those in the NS group (2.26 ± 1.15); [p < 0.001; CI: 0.78-1.82]. More children in the HS group (n = 35/50; 70.0%) were eligible for ER/OPD discharge at the end of 2 h than those in the NS group (n = 15/50; 30%; p < 0.001), and less likely to need a hospital re-visit (n = 5/50; 10.0%) in the next 24 h as compared to the NS group (n = 15/50, 30.0%; p < 0.001). The treatment was well tolerated, with no adverse effects. CONCLUSIONS: Nebulized 3% HS is effective, safe and superior to normal saline for outpatient management of infants with mild to moderately severe viral bronchiolitis in improving Clinical Severity Scores, facilitating early Out-Patient Department discharge and preventing hospital re-visits and admissions in the 24 h of presentation. TRIAL REGISTRATION: Clinicaltrials.gov NCTID012766821. Registered on January 12, 2011. More... »

PAGES

115

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12887-015-0434-4

DOI

http://dx.doi.org/10.1186/s12887-015-0434-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031924287

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26357896


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Inhalation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bronchiolitis, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bronchodilator Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Emergency Service, Hospital", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epinephrine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nebulizers and Vaporizers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Saline Solution, Hypertonic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal", 
          "id": "http://www.grid.ac/institutes/grid.412809.6", 
          "name": [
            "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khanal", 
        "givenName": "Aayush", 
        "id": "sg:person.01255000307.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255000307.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal", 
          "id": "http://www.grid.ac/institutes/grid.412809.6", 
          "name": [
            "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sharma", 
        "givenName": "Arun", 
        "id": "sg:person.01244157626.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244157626.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal", 
          "id": "http://www.grid.ac/institutes/grid.412809.6", 
          "name": [
            "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Basnet", 
        "givenName": "Srijana", 
        "id": "sg:person.01371226707.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371226707.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal", 
          "id": "http://www.grid.ac/institutes/grid.415089.1", 
          "name": [
            "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal", 
            "Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sharma", 
        "givenName": "Pushpa Raj", 
        "id": "sg:person.012020420352.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012020420352.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal", 
          "id": "http://www.grid.ac/institutes/grid.412809.6", 
          "name": [
            "Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gami", 
        "givenName": "Fakir Chandra", 
        "id": "sg:person.01034414307.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034414307.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2288-4-26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006015397", 
          "https://doi.org/10.1186/1471-2288-4-26"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004310050798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039972836", 
          "https://doi.org/10.1007/s004310050798"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-09-10", 
    "datePublishedReg": "2015-09-10", 
    "description": "BACKGROUND: To Assess the efficacy of nebulised hypertonic saline (HS) (3%) among children with mild to moderately severe bronchiolitis.\nMETHODS: Infants aged 6 weeks to 24 months, with a first episode of wheezing and Clinical Severity scores (Arch Dis Child 67:289-93, 1992) between 1 and 8, were enrolled over 4 months duration. Those with severe disease, co-morbidities, prior wheezing, recent bronchodilator and steroid use were excluded. Patients were randomized in a double-blind fashion, to receive two doses of nebulized 3% HS (Group 1) or 0.9% normal saline (Group 2) with 1.5 mg of L-Epineprine, delivered 30 min apart. Parents were contacted at 24 h and 7 days. The principal outcome measure was the mean change in clinical severity score at the end of 2 h of observation.\nRESULTS: A total of 100 infants (mean age 9.6 months, range 2-23 months; 61 % males) were enrolled. Patients in both groups had mild to moderately severe disease at presentation. On an intention-to-treat basis, the infants in the HS group had a significant reduction (3.57 \u00b1 1.41) in the mean clinical severity score compared to those in the NS group (2.26 \u00b1 1.15); [p < 0.001; CI: 0.78-1.82]. More children in the HS group (n = 35/50; 70.0%) were eligible for ER/OPD discharge at the end of 2 h than those in the NS group (n = 15/50; 30%; p < 0.001), and less likely to need a hospital re-visit (n = 5/50; 10.0%) in the next 24 h as compared to the NS group (n = 15/50, 30.0%; p < 0.001). The treatment was well tolerated, with no adverse effects.\nCONCLUSIONS: Nebulized 3% HS is effective, safe and superior to normal saline for outpatient management of infants with mild to moderately severe viral bronchiolitis in improving Clinical Severity Scores, facilitating early Out-Patient Department discharge and preventing hospital re-visits and admissions in the 24 h of presentation.\nTRIAL REGISTRATION: Clinicaltrials.gov NCTID012766821. Registered on January 12, 2011.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12887-015-0434-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024635", 
        "issn": [
          "1471-2431"
        ], 
        "name": "BMC Pediatrics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "clinical severity score", 
      "hypertonic saline", 
      "severity score", 
      "NS group", 
      "severe bronchiolitis", 
      "normal saline", 
      "severe disease", 
      "HS group", 
      "mean clinical severity score", 
      "double-blind fashion", 
      "severe viral bronchiolitis", 
      "principal outcome measure", 
      "treat basis", 
      "outpatient management", 
      "viral bronchiolitis", 
      "steroid use", 
      "months duration", 
      "first episode", 
      "outcome measures", 
      "mean change", 
      "bronchiolitis", 
      "infants", 
      "adverse effects", 
      "saline", 
      "more children", 
      "patients", 
      "significant reduction", 
      "scores", 
      "hospital", 
      "mild", 
      "disease", 
      "children", 
      "group", 
      "presentation", 
      "epineprine", 
      "bronchodilators", 
      "admission", 
      "doses", 
      "trials", 
      "weeks", 
      "months", 
      "efficacy", 
      "episodes", 
      "treatment", 
      "discharge", 
      "total", 
      "duration", 
      "days", 
      "min", 
      "management", 
      "parents", 
      "measures", 
      "end", 
      "reduction", 
      "effect", 
      "changes", 
      "fashion", 
      "use", 
      "intention", 
      "observations", 
      "basis", 
      "recent bronchodilator", 
      "ER/OPD discharge", 
      "OPD discharge", 
      "early Out-Patient Department discharge", 
      "Out-Patient Department discharge", 
      "Department discharge", 
      "NCTID012766821"
    ], 
    "name": "Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial", 
    "pagination": "115", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031924287"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12887-015-0434-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26357896"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12887-015-0434-4", 
      "https://app.dimensions.ai/details/publication/pub.1031924287"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_659.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12887-015-0434-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12887-015-0434-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12887-015-0434-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12887-015-0434-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12887-015-0434-4'


 

This table displays all metadata directly associated to this object as RDF triples.

229 TRIPLES      22 PREDICATES      111 URIs      101 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12887-015-0434-4 schema:about N11146568a0fd4547a25f790238e55cbc
2 N23c1260bdde940afa4737d7ddcc49a20
3 N2b29a40b1c014102a0988baff7cc2c21
4 N312cffb92428491ea86915880c4e6b71
5 N3b41bfc7cfd84f29b070a58cc2bf9001
6 N556f24100eba4b32b7d4481228777780
7 N567d189b04aa41b7a86f58b733361f41
8 N66a5362cec3d490bbb57b09d8b0aa6b7
9 N90eea6d052754f728c981cd4971d1fc6
10 N9559bb160e31432aad37008264d1b573
11 Na3b4002aad764af79149822fa0ac2097
12 Nbdecab54912e47e8a0586609bb4c2f75
13 Nc3fe1aaecd7042318ce7faeb743e6fd2
14 Nd4874ca795df4635bafc4d8bcfe18b2b
15 Nf313cefd4b8a48589c08f7fb08110889
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N8200bb3b315d48f49c0b47479500a2dd
19 schema:citation sg:pub.10.1007/s004310050798
20 sg:pub.10.1186/1471-2288-4-26
21 schema:datePublished 2015-09-10
22 schema:datePublishedReg 2015-09-10
23 schema:description BACKGROUND: To Assess the efficacy of nebulised hypertonic saline (HS) (3%) among children with mild to moderately severe bronchiolitis. METHODS: Infants aged 6 weeks to 24 months, with a first episode of wheezing and Clinical Severity scores (Arch Dis Child 67:289-93, 1992) between 1 and 8, were enrolled over 4 months duration. Those with severe disease, co-morbidities, prior wheezing, recent bronchodilator and steroid use were excluded. Patients were randomized in a double-blind fashion, to receive two doses of nebulized 3% HS (Group 1) or 0.9% normal saline (Group 2) with 1.5 mg of L-Epineprine, delivered 30 min apart. Parents were contacted at 24 h and 7 days. The principal outcome measure was the mean change in clinical severity score at the end of 2 h of observation. RESULTS: A total of 100 infants (mean age 9.6 months, range 2-23 months; 61 % males) were enrolled. Patients in both groups had mild to moderately severe disease at presentation. On an intention-to-treat basis, the infants in the HS group had a significant reduction (3.57 ± 1.41) in the mean clinical severity score compared to those in the NS group (2.26 ± 1.15); [p < 0.001; CI: 0.78-1.82]. More children in the HS group (n = 35/50; 70.0%) were eligible for ER/OPD discharge at the end of 2 h than those in the NS group (n = 15/50; 30%; p < 0.001), and less likely to need a hospital re-visit (n = 5/50; 10.0%) in the next 24 h as compared to the NS group (n = 15/50, 30.0%; p < 0.001). The treatment was well tolerated, with no adverse effects. CONCLUSIONS: Nebulized 3% HS is effective, safe and superior to normal saline for outpatient management of infants with mild to moderately severe viral bronchiolitis in improving Clinical Severity Scores, facilitating early Out-Patient Department discharge and preventing hospital re-visits and admissions in the 24 h of presentation. TRIAL REGISTRATION: Clinicaltrials.gov NCTID012766821. Registered on January 12, 2011.
24 schema:genre article
25 schema:inLanguage en
26 schema:isAccessibleForFree true
27 schema:isPartOf N0ec68550bef94d5189844c32dd9c173e
28 N92d3352cf2a44a5b96144745f4bede70
29 sg:journal.1024635
30 schema:keywords Department discharge
31 ER/OPD discharge
32 HS group
33 NCTID012766821
34 NS group
35 OPD discharge
36 Out-Patient Department discharge
37 admission
38 adverse effects
39 basis
40 bronchiolitis
41 bronchodilators
42 changes
43 children
44 clinical severity score
45 days
46 discharge
47 disease
48 doses
49 double-blind fashion
50 duration
51 early Out-Patient Department discharge
52 effect
53 efficacy
54 end
55 epineprine
56 episodes
57 fashion
58 first episode
59 group
60 hospital
61 hypertonic saline
62 infants
63 intention
64 management
65 mean change
66 mean clinical severity score
67 measures
68 mild
69 min
70 months
71 months duration
72 more children
73 normal saline
74 observations
75 outcome measures
76 outpatient management
77 parents
78 patients
79 presentation
80 principal outcome measure
81 recent bronchodilator
82 reduction
83 saline
84 scores
85 severe bronchiolitis
86 severe disease
87 severe viral bronchiolitis
88 severity score
89 significant reduction
90 steroid use
91 total
92 treat basis
93 treatment
94 trials
95 use
96 viral bronchiolitis
97 weeks
98 schema:name Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial
99 schema:pagination 115
100 schema:productId N34dd1c10b8e3438893123a047fac1be4
101 N764de7b21163445bb502a3c7d182699c
102 Nd01c6f61f7ab46ee8be48c335123251d
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031924287
104 https://doi.org/10.1186/s12887-015-0434-4
105 schema:sdDatePublished 2022-01-01T18:35
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher N924da86d7b564d669e7611040f1cf01a
108 schema:url https://doi.org/10.1186/s12887-015-0434-4
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N0ec68550bef94d5189844c32dd9c173e schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 N11146568a0fd4547a25f790238e55cbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Bronchodilator Agents
116 rdf:type schema:DefinedTerm
117 N23c1260bdde940afa4737d7ddcc49a20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Administration, Inhalation
119 rdf:type schema:DefinedTerm
120 N29eff7a34e9341eabf9e3f37d79075aa rdf:first sg:person.01034414307.70
121 rdf:rest rdf:nil
122 N2b29a40b1c014102a0988baff7cc2c21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Epinephrine
124 rdf:type schema:DefinedTerm
125 N312cffb92428491ea86915880c4e6b71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Infant
127 rdf:type schema:DefinedTerm
128 N34dd1c10b8e3438893123a047fac1be4 schema:name dimensions_id
129 schema:value pub.1031924287
130 rdf:type schema:PropertyValue
131 N3b41bfc7cfd84f29b070a58cc2bf9001 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Severity of Illness Index
133 rdf:type schema:DefinedTerm
134 N556f24100eba4b32b7d4481228777780 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Bronchiolitis, Viral
136 rdf:type schema:DefinedTerm
137 N567d189b04aa41b7a86f58b733361f41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Treatment Outcome
139 rdf:type schema:DefinedTerm
140 N5932fd1fbb6844e1b6c1bd491445b061 rdf:first sg:person.012020420352.44
141 rdf:rest N29eff7a34e9341eabf9e3f37d79075aa
142 N66a5362cec3d490bbb57b09d8b0aa6b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Male
144 rdf:type schema:DefinedTerm
145 N762eb16c92e246beb98137d22af140b3 rdf:first sg:person.01371226707.45
146 rdf:rest N5932fd1fbb6844e1b6c1bd491445b061
147 N764de7b21163445bb502a3c7d182699c schema:name pubmed_id
148 schema:value 26357896
149 rdf:type schema:PropertyValue
150 N8200bb3b315d48f49c0b47479500a2dd rdf:first sg:person.01255000307.52
151 rdf:rest Na3128fecf9a94f9cbbc8d9fa7e2c615c
152 N90eea6d052754f728c981cd4971d1fc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Nebulizers and Vaporizers
154 rdf:type schema:DefinedTerm
155 N924da86d7b564d669e7611040f1cf01a schema:name Springer Nature - SN SciGraph project
156 rdf:type schema:Organization
157 N92d3352cf2a44a5b96144745f4bede70 schema:volumeNumber 15
158 rdf:type schema:PublicationVolume
159 N9559bb160e31432aad37008264d1b573 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Emergency Service, Hospital
161 rdf:type schema:DefinedTerm
162 Na3128fecf9a94f9cbbc8d9fa7e2c615c rdf:first sg:person.01244157626.70
163 rdf:rest N762eb16c92e246beb98137d22af140b3
164 Na3b4002aad764af79149822fa0ac2097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Double-Blind Method
166 rdf:type schema:DefinedTerm
167 Nbdecab54912e47e8a0586609bb4c2f75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Saline Solution, Hypertonic
169 rdf:type schema:DefinedTerm
170 Nc3fe1aaecd7042318ce7faeb743e6fd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Drug Therapy, Combination
172 rdf:type schema:DefinedTerm
173 Nd01c6f61f7ab46ee8be48c335123251d schema:name doi
174 schema:value 10.1186/s12887-015-0434-4
175 rdf:type schema:PropertyValue
176 Nd4874ca795df4635bafc4d8bcfe18b2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Humans
178 rdf:type schema:DefinedTerm
179 Nf313cefd4b8a48589c08f7fb08110889 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Female
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:journal.1024635 schema:issn 1471-2431
189 schema:name BMC Pediatrics
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.01034414307.70 schema:affiliation grid-institutes:grid.412809.6
193 schema:familyName Gami
194 schema:givenName Fakir Chandra
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034414307.70
196 rdf:type schema:Person
197 sg:person.012020420352.44 schema:affiliation grid-institutes:grid.415089.1
198 schema:familyName Sharma
199 schema:givenName Pushpa Raj
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012020420352.44
201 rdf:type schema:Person
202 sg:person.01244157626.70 schema:affiliation grid-institutes:grid.412809.6
203 schema:familyName Sharma
204 schema:givenName Arun
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244157626.70
206 rdf:type schema:Person
207 sg:person.01255000307.52 schema:affiliation grid-institutes:grid.412809.6
208 schema:familyName Khanal
209 schema:givenName Aayush
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255000307.52
211 rdf:type schema:Person
212 sg:person.01371226707.45 schema:affiliation grid-institutes:grid.412809.6
213 schema:familyName Basnet
214 schema:givenName Srijana
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371226707.45
216 rdf:type schema:Person
217 sg:pub.10.1007/s004310050798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039972836
218 https://doi.org/10.1007/s004310050798
219 rdf:type schema:CreativeWork
220 sg:pub.10.1186/1471-2288-4-26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006015397
221 https://doi.org/10.1186/1471-2288-4-26
222 rdf:type schema:CreativeWork
223 grid-institutes:grid.412809.6 schema:alternateName Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal
224 schema:name Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal
225 rdf:type schema:Organization
226 grid-institutes:grid.415089.1 schema:alternateName Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal
227 schema:name Department of Pediatrics, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj-44600, P.O. Box 1524, Kathmandu, Nepal
228 Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal
229 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...